1. Market Research
  2. > Healthcare
  3. > Blood Supply, Tissue Banking and Transplantation Market Trends
  4. > Blood Screening and Typing Markets

Blood Screening and Typing Markets

  • January 2016
  • -
  • Kalorama Information
  • -
  • 117 pages

Blood Screening and Typing Markets examines the infectious disease blood typing and the infectious disease blood screening markets, including complete market analysis of the blood screening and typing markets:
Worldwide Blood Typing and Screening Sales, 2015 and 2020 (ABO Grouping, Immunoassay Screen, NAT Screen)
Selected Blood Typing Innovations
Blood Typing by Country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
Infectious Disease Blood Typing Market Share by Company
Immunoassay Testing Market by Country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
Selected New Blood Screening Immunoassays
NAT Blood Screening Market by Country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
Selected New Blood Screen NAT Tests and Systems
Infectious Disease Blood Screening Test Market Share by Company

A variety of infectious agents can be present in blood, including viruses, bacteria, protozoans, Chagas disease, Lyme Disease, and prions. Blood typing and testing represents the cornerstone of ensuring that transfused blood is safe for the recipient and free of disease. The report provides a comprehensive overview of the blood screening and typing markets, discussing:

Risk of Contamination
Viral Inactivation by Procedure
Basic Blood Types
Blood Transfusion Compatibility
PCR-Based Screening Tests Licensed by CBER
Comparison of Direct and Indirect ELISA Tests

Laboratory Screening of Blood Donations for Transfusion-Transmissible Infections, Number of Countries
Blood Component Usage
Pathogens Commonly Tested in Donated Blood Units
Selected Pathogen Screening Innovations
Blood Screening and Typing Markets profiles a selection of companies that specialize in blood banking and that contribute molecular test innovation to this segment. Companies discussed include Grifols and Roche Diagnostics.

Table Of Contents

Blood Screening and Typing Markets
ONE: EXECUTIVE SUMMARY
Blood Screening
Blood Typing
The Market for Blood Testing and Typing
TWO: INTRODUCTION
Reducing Blood Typing Errors
Improving Donor Screening
Improving Viral Screening
Increasing Repeat Donation Rates
Enhancing Viral Inactivation Processes
Increasing Voluntary Donation
Preventing Bacterial Infections
Biovigilance
Other Safety Precautions
Blood Typing
Methods of Blood Typing
Blood Testing
Nucleic Acid Amplification Testing (NAT)
CBER Licensed NAT Screening Tests
Polymerase Chain Reaction (PCR) Amplification
CBER Licensed PCR Screening Tests
Immunoassay
Enzyme-Linked Immunosorbent Assay
Costs and Other Barriers
Blood Storage
Blood Transfusions
Blood Pathogen Screening
THREE: MARKET ANALYSIS
Blood Banking Gets a Shakeup
Blood Typing
Blood Grouping and Typing
Immunoassays
Nucleic Acid Testing (NAT)
Market Share in Blood Testing
FOUR: COMPANY PROFILES
Abbott Diagnostics
AXO Science
Beckman Coulter
bioMerieux Inc
Cerus Corporation
DiaSorin S.p.A
Grifols
Blood Transfusion Novartis Business
International Programs
Haemonetics Corporation
Hologic, Inc.
Product News
The Gen-Probe Business
Panther System
Blood Bank
Quest Contract
Immucor, Inc.
Immunetics Inc.
Ortho Clinical Diagnostics
Quotient Limited
Roche Diagnostics
Terumo BCT
Verax Biomedical Inc.


LIST OF EXHIBITS
ONE: EXECUTIVE SUMMARY
Figure 1-1: The Market for Blood Testing and Typing, 2015 and 2020
TWO: INTRODUCTION
Table 2-1: Risk of Contamination
Table 2-2: Viral Inactivation by Procedure
Table 2-3: Basic Blood Types
Table 2-4: Blood Transfusion Compatibility
Table 2-5: PCR-Based Screening Tests Licensed by CBER
Table 2-6: Comparison of Direct and Indirect ELISA Tests
Table 2-7: Laboratory Screening of Blood Donations for Transfusion-Transmissible Infections, Number of Countries
Table 2-8: Blood Component Usage
Table 2-9: Pathogens Commonly Tested in Donated Blood Units
Table 2-10: Selected Pathogen Screening Innovations
THREE: MARKET ANALYSIS
Table 3-1: Worldwide Blood Typing and Screening Sales, 2015 and 2020 (ABO Grouping, Immunoassay Screen, NAT Screen)
Figure 3-1: Worldwide Blood Typing and Screening Sales, 2015 and 2020 (ABO Grouping, Immunoassay Screen, NAT Screen)
Table 3-2: Selected Blood Typing Innovations
Figure 3-2: Blood Typing by Country, 2015 (United States, Italy, Germany, UK,
France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
Table 3-3: Infectious Disease Blood Typing Market Share by Company
Figure 3-3: Immunoassay Testing Market by Country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
Table 3-4: Selected New Blood Screening Immunoassays
Figure 3-4: NAT Blood Screening Market by Country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
Table 3-5: Selected New Blood Screen NAT Tests and Systems
Table 3-6: Infectious Disease Blood Screening Test Market Share by Company

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2017-2021 Molecular Diagnostics and NAT Market: Supplier Shares and Market Segment Forecasts by Country

2017-2021 Molecular Diagnostics and NAT Market: Supplier Shares and Market Segment Forecasts by Country

  • $ 9850
  • Industry report
  • December 2016
  • by Venture Planning Group

This report provides the following data: Geographic Coverage:-          France-          Germany-          Italy-          Japan-          Spain-          ...

Blood Screening Market by Technology, ELISA,, Rapid Test, NGS, Western Blotting), Product & End User - Global Forecasts to 2021

Blood Screening Market by Technology, ELISA,, Rapid Test, NGS, Western Blotting), Product & End User - Global Forecasts to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The blood screening market is expected to reach USD 2.80 billion by 2021 from USD 1.76 billion in 2016, at a CAGR of 9.7%. The global blood screening market is categorized based on technology, product ...

Blood Screening Market Analysis By Technology (Nucleic Acid Amplification Test, ELISA, Chemiluminescence Immunoassay And Enzyme Immunoassay, Next-Generation Sequencing, And Western Blotting) And By Product And Segment Forecasts, 2013 - 2024

Blood Screening Market Analysis By Technology (Nucleic Acid Amplification Test, ELISA, Chemiluminescence Immunoassay And Enzyme Immunoassay, Next-Generation Sequencing, And Western Blotting) And By Product And Segment Forecasts, 2013 - 2024

  • $ 4950
  • Industry report
  • October 2016
  • by Grand View Research

The global blood screening market is expected to reach a value of USD 3.9 billion by 2024, based on a new report by Grand View Research, Inc. The growth of the market is attributed to the increasing screening ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.